ArticlePatient preference and adherence2018

Treatment satisfaction significantly improves in patients with multiple sclerosis switching from interferon beta therapy to peginterferon beta-1a every 2 weeks.

Barry Hendin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.